- Overview
-
My research focuses on improving the understanding of how chromosomal abnormalities result in an abnormal phenotype (e.g., cancer, malformations, or intellectual disability). I am also interested in the applications of genomics to the area of clinical diagnosis.
- Research
-
Grants
2011/9-2016/9 Rare Obesity Disorders Informing Common Disease, CIHR Operating Grant; Co-investigator (PI: William Gibson)
2010/9-2011/9 Rare Obesity Disorders Informing Common Disease, CIHR Operating Grant INMD Start-up Funds; Co-investigator (PI: William Gibson)
Research Group MembersDavid Chai, Clinical Laboratory Technologist
Kathryn Hepburn, Cytogenetics Technologist
Duda Markovic, Lab Assistant
Wing Mung, Cytogenetics Technologist
OPTIMISE trial seeks to personalize cancer treatment for children with high-risk tumours
Dr. Rebecca Deyell will be leading the OPTIMISE trial — short for Optimal Precision Therapies to CustoMISE Care in Childhood and Adolescent Cancer — at BC Children's Hospital. The trial is designed to match children, adolescents and young adults with high-risk cancers to targeted therapies based on the genetic makeup of their tumours.
